Can 3D-Printed implants rebuild severely deformed limbs?

NCT ID NCT07779278

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 21, 2026 · Last updated Aug 21, 2026

Summary

This study looks at whether custom-made, 3D-printed implants can help people with severe limb bone deformities—such as bending, shortening, or rotation—caused by injury, infection, or birth conditions. Researchers will follow 30 adults who receive these personalized implants as part of a multi-step surgical plan. The goal is to see if the implants stay stable, correct the deformity, and allow the limb to function normally over a year.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Patient-specific porous titanium (Ti6Al4V) implants created via 3D printing, guided by computer-assisted surgical planning
What this could lead to
If successful, this approach could offer a more precise, personalized way to reconstruct severely deformed limb bones, potentially improving function and reducing the need for multiple surgeries.
What could go wrong
This is an early-stage observational study with only 30 participants, so results may not apply broadly. Risks include implant failure, infection, or incomplete bone healing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Jul 2031

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will consist of consecutively identified adults receiving care at participating tertiary referral hospitals for complex deformity of a major upper- or lower-limb bone. Eligible deformities may result from post-traumatic malunion or nonunion, infection-related sequelae, tumour-related bone resection, congenital or developmental conditions, iatrogenic deformity or failed previous reconstruction. Participants may have angular deformity, shortening, rotational deformity or a combination of these, together with structural bone deficiency requiring patient-specific reconstruction. Eligibility for treatment and all surgical decisions will be determined by the treating multidisciplinary team independently of study participation.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 years or older. Complex deformity involving a major upper- or lower-limb bone, including the humerus, radius, ulna, femur or tibia. Angular deformity, shortening, rotational deformity or any combination of these. Structural bone deficiency present before treatment or anticipated after corrective osteotomy, debridement or bone resection. The treating multidisciplinary team determines that a patient-specific additively manufactured implant is clinically indicated to restore skeletal continuity, length, alignment, rotation or mechanical load transfer. Ability to undergo CT-based three-dimensional planning and the planned multistage reconstructive treatment. Ability to provide written informed consent and willingness to complete 12 months of follow-up after definitive reconstruction. Exclusion Criteria: * Isolated osteoarthritis-related deformity without a reconstructive limb bone defect. Acute fracture without an established deformity or structural bone deficiency requiring patient-specific reconstruction. Uncontrolled systemic infection. Severe vascular insufficiency or a soft-tissue condition that precludes definitive reconstruction. Anticipated inability to achieve adequate debridement when required, viable soft-tissue coverage or stable fixation. Known allergy or contraindication to the implant material. Pregnancy when the required imaging or surgery would be inappropriate. Inability to comply with rehabilitation or outcome assessments. Participation in another clinical study that could materially affect the study outcomes.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Angular deformity are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Peking University Third Hospital

    Beijing, Beijing Municipality, 100191, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.